A Novel Hydroxyapatite Fiber Mesh as a Carrier for Recombinant Human Bone Morphogenetic Protein-2 Enhances Bone Union in Rat Posterolateral Fusion Model
- 1 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 31 (11) , 1194-1200
- https://doi.org/10.1097/01.brs.0000217679.46489.1b
Abstract
An experimental study, in which spinal fusion in rats was conducted using a hydroxyapatite fiber mesh (HAM) as a carrier for recombinant human bone morphogenetic protein (rhBMP)-2. To study the usefulness of the HAM as a carrier and seek the possibility of clinical application in spinal fusion. Several biomaterials have been used as a carrier for BMP to achieve spine fusion, however, to our knowledge, the most effective carrier has not been established. In experiment No. 1, HAMs and the controls (commercially available hydroxyapatite ceramic body), loaded with rhBMP-2, were immersed in phosphate-buffered saline to evaluate the time course of the release of rhBMP-2. In experiment No. 2, posterolateral fusion was conducted in rats using HAM and the control loaded with rhBMP-2. The fusion status was evaluated radiologically and histologically after surgery. In experiment No. 1, HAMs released a larger amount of rhBMP-2 for up to 28 days than the controls (49.5% vs 7.8%). In experiment No. 2, the fusion rate was significantly higher in the HAM group (>80%) than in the control group (20%). Dense new bone formed close to the spine, and the HAMs were markedly absorbed compared with the controls. HAM provided more solid fusion mass than the control, suggesting that HAM is an efficient carrier for BMP.Keywords
This publication has 18 references indexed in Scilit:
- Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphateBiomaterials, 2005
- The effect of basic fibroblast growth factor on bone regeneration when released from a novelin situsetting tricalcium phosphate cementJournal of Biomedical Materials Research Part A, 2004
- Delivery systems for bone growth factors — the new players in skeletal regenerationJournal of Pharmacy and Pharmacology, 2004
- Experimental study of carriers of bone morphogenetic protein used for spinal fusionJournal of Orthopaedic Science, 2004
- RHBMP-2 RELEASE FROM INJECTABLE POLY(DL-LACTIC-CO-GLYCOLIC ACID)/CALCIUM-PHOSPHATE CEMENT COMPOSITESJournal of Bone and Joint Surgery, 2003
- Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in HumansSpine, 2002
- Retention of 125I‐labeled recombinant human bone morphogenetic protein‐2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis modelJournal of Orthopaedic Research, 2002
- Delivery of Recombinant Human Bone Morphogenetic Protein-2 Using a Compression-Resistant Matrix in Posterolateral Spine Fusion in the Rabbit and in the Non-Human PrimateSpine, 2002
- Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2Clinical Orthopaedics and Related Research, 2002
- The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion ModelSpine, 1999